These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33822517)

  • 1. SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway.
    Chen Q; Sun Z; Li J; Zhang D; Guo B; Zhang T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):55-63. PubMed ID: 33822517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients.
    Yu H; Sun J; Zhao C; Wang H; Liu Y; Xiong J; Chang J; Wang M; Wang W; Ye D; Zhou H; Yu T
    BMC Cancer; 2019 Jul; 19(1):736. PubMed ID: 31345185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of SETD5 Inhibits Colorectal Cancer Cell Growth and Stemness by Regulating PI3K/AKT/mTOR Pathway.
    Zhou X; Chen W; Zhuang D; Xu G; Puyang Y; Rui H
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38641699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.
    Liang Z; Zhong Y; Meng L; Chen Y; Liu Y; Wu A; Li X; Wang M
    Thorac Cancer; 2020 Nov; 11(11):3155-3167. PubMed ID: 32926529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
    Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
    Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway.
    Yiyan S; Yang S; Li D; Li W
    Curr Cancer Drug Targets; 2022; 22(1):86-95. PubMed ID: 34325639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
    Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.
    Zhu Q; Liang X; Dai J; Guan X
    Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.